Rezultati pretraživanja
  1. 4. velj

    If you are at the , make sure you attend the "Go big or go home? Evolving early strategies" panel with the representatives from , , Ventures, Life Science Ventures and

  2. 8. sij

    -focused Copenhagen-based has closed its Series B round at $40M. New US investors are , which led round, & Investments and were joined by existing backers , , New Science Ventures & Ventures

  3. 19. pro 2019.
  4. 14. stu 2019.
  5. 17. lis 2019.

    Where is early stage funding going to and where will it lead to? questions , , , ,

  6. 17. ruj 2019.

    We are proud to announce that our client was shortlisted as one of the finalists for the the LSX ‘European of the Year’ category! Congratulations!

  7. Novo Seeds Announces Record Year for Investment and Company Creation

  8. 29. stu 2018.

    ' Stephan Christgau discusses key developments at the firm and among its portfolio over the last decade, as well as its aims for the next 10 years:

  9. 28. stu 2018.

    Propelling life science innovation from pre-seed to patients - Stephan Christgau discusses key developments at the firm, its portfolio & how it is working to bolster entrepreneurial talent & research prospects in the sector

  10. 27. stu 2018.

    “There are some indications which maybe haven’t received as much attention, but where we have found some really interesting opportunities” - ' Stephan Christgau. Read more:

  11. 2. stu 2018.

    Emerging from incubation supported by , Embark ApS secures research collaboration with for discovery of novel treatments for & associated metabolic pathologies thru mechanisms that increase energy expenditure.

  12. 26. lis 2018.

    Portfolio Company Galecto Biotech Raises €79 Million in Series C Financing - Novo Seeds invests €12.5 million becoming largest shareholder. Congratulations to

  13. 11. sij 2018.

    Read leading ’ thoughts on the current state of and seed funding: With thanks to @AlbionCap

  14. 3. lip 2017.
  15. 6. velj 2017.

    Seminarium m Diana Mutic fr om stöd till tidiga projekt inom samarr m o Bio-inst

  16. 14. ruj 2016.
  17. 31. kol 2016.

    to moderate plenary session & Soren Moller to discuss market Nov30

  18. 14. lip 2016.

Čini se da učitavanje traje već neko vrijeme.

Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.